Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 45,000 | |||
5 mg | 在庫あり | ¥ 102,500 | |||
10 mg | 在庫あり | ¥ 151,500 | |||
25 mg | 在庫あり | ¥ 226,500 | |||
50 mg | 在庫あり | ¥ 317,000 | |||
100 mg | 在庫あり | ¥ 434,000 | |||
500 mg | 在庫あり | ¥ 870,000 |
説明 | GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM. |
ターゲット&IC50 | GSK-3β:﹥ 100μM |
別名 | 1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)- |
分子量 | 283.39 |
分子式 | C17H17NOS |
CAS No. | 863004-48-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.7 mg/mL (9.5 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-3β inhibitor 14 863004-48-2 PI3K/Akt/mTOR signaling Stem Cells GSK-3 GSK-3beta inhibitor 14 GSK-3b inhibitor 14 1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)- Inhibitor inhibitor inhibit